Digital Medicine attracted over $8 Billion in venture capital in 2018 with promises of “driving down costs and empowering consumers to take charge of their health”. The Yale Digital Medicine Symposium explores the current state and future potential of digital health. Speakers included entrepreneurs and national experts on artificial intelligence, health data outcomes, CEO’s from digital health companies and academia.
Ethical Considerations, Digital Medicine
Jennifer Miller, PhD| Yale School of Medicine
 
Closing Remarks and Acknowledgements
Michael Dempsey | Yale Center for Biomedical Innovation and Technology

свернуть